Home > News > Volunteer enrolments commence for Vivagel™ Phase 1 Study
November 12th, 2003
Volunteer enrolments commence for Vivagel™ Phase 1 Study
Abstract:
Starpharma Pooled Development Limited is pleased to announce that volunteer enrolment has now commenced for the VivaGel™ Phase I human safety study following receipt of final ethical approval from the Royal Adelaide Hospital Ethics Committee. This trial of VivaGel™ is creating a precedent as it is the first dendrimer nano-drug to advance to clinical trials under the FDA regulatory system.
Source:
Starpharma
Bookmark:
| Related News Press |
Nanomedicine
New micromaterial releases nanoparticles that selectively destroy cancer cells April 5th, 2024
Good as gold - improving infectious disease testing with gold nanoparticles April 5th, 2024
Researchers develop artificial building blocks of life March 8th, 2024
 |
||
 |
||
| The latest news from around the world, FREE | ||
 |
||
|
|
||
| Premium Products | ||
 |
||
|
Only the news you want to read!
Learn More |
||
 |
||
|
Full-service, expert consulting
Learn More |
||
|
|
||